Molecular Biology of Huntington's Disease

被引:0
|
作者
Ersoy, Nagehan [1 ]
Basak, A. Nazli [1 ]
机构
[1] Bogazici Univ, Mol Biyol & Genet Bolumu, TR-34342 Bebek, Turkey
关键词
Huntington's Disease; polyglutamine diseases; CAG repeats; neurodegeneration;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's Disease ( HD) is the most common among nine known polyglutamine disorders. Its prevalence is estimated to be 3-7/100 000 in populations of Western European descent. HD is an autosomal dominantly inherited neurodegenerative disorder of the central nervous system, characterized by involuntary movements, impaired motor coordination, cognitive loss and various psychiatric abnormalities. The most prominent pathological finding is the selective neuron death in basal ganglia. The disease gene ( IT-15), localized to chromosome 4 in 1993 and 180kb long, is composed of 67 exons. The gene product is a 348 kDa protein, called huntingtin, whose function is not known yet. The mutation causing HD is the expansion of the CAG triplet repeat in the first exon of the IT-15 gene. Huntington's Disease Working Group has identified four repeat intervals: People who carry 26 or less CAG repeats in the IT-15 gene are healthy, alleles with 27-35 repeats may show intergenerational instability, people carrying 36-39 CAG repeats may or may not develop the disease, however 40 or more CAG repeats definitely cause HD, if people live long enough. The molecular diagnosis of HD with direct mutation analysis has been available since 1993. In this method, the CAG repeat region on the IT15 gene is PCR-amplified, and the repeat number is determined using radioactive
引用
收藏
页码:27 / 44
页数:16
相关论文
共 50 条
  • [21] Astrocyte molecular signatures in Huntington's disease
    Diaz-Castro, Blanca
    Gangwani, Mohitkumar R.
    Yu, Xinzhu
    Coppola, Giovanni
    Khakh, Baljit S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (514)
  • [22] Insights into the molecular pathogenesis of Huntington's disease
    Bates, G
    [J]. JOURNAL OF MEDICAL GENETICS, 2001, 38 : S30 - S30
  • [23] Huntington\'s disease: Biology, therapeutic strategies, and translational challenges
    Munoz-Sanjuan, Ignacio
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [24] Huntington's disease-like 2: a clinical, pathological, and molecular comparison to Huntington's disease
    Margolis, RL
    Holmes, SE
    [J]. CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 187 - 196
  • [25] Molecular biology of Hodgkin's disease
    Stein, H
    Hummel, M
    Marafioti, T
    Anagnostopoulos, I
    Foss, HD
    [J]. CANCER SURVEYS, 1997, 30 : 107 - 123
  • [26] Molecular Biology of Alzheimer's Disease
    Yokes, M. Baki
    Basak, A. Nazli
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2005, 11 (02) : 201 - 222
  • [27] Toward understanding the molecular pathology of Huntington's Disease
    Wellington, CL
    Brinkman, RR
    OKusky, JR
    Hayden, MR
    [J]. BRAIN PATHOLOGY, 1997, 7 (03) : 979 - 1002
  • [28] Toward understanding the molecular pathology of Huntington's disease
    Brouillet, E
    Peschanski, M
    Hantraye, P
    [J]. M S-MEDECINE SCIENCES, 2000, 16 (01): : 57 - 63
  • [29] Molecular analysis of uruguayan families with Huntington's disease
    Raggio, V.
    Bidegain, E.
    Vital, M.
    Buzo, R.
    Lescano, A.
    de Medina, O.
    Amorin, I.
    Dieguez, E.
    Ventura, R.
    Rodriguez, M. M.
    Esperon, P.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S214 - S214
  • [30] Molecular Targets and Therapeutic Strategies in Huntington's Disease
    Cristina Rego, A.
    de Almeida, Luis Pereira
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (04) : 361 - 381